Innate Cellular Immunity in Newly Diagnosed Pulmonary Tuberculosis Patients and During Chemotherapy.

@article{Edem2015InnateCI,
  title={Innate Cellular Immunity in Newly Diagnosed Pulmonary Tuberculosis Patients and During Chemotherapy.},
  author={Victory Fabian Edem and Ganiyu Olatunbosun Arinola},
  journal={Annals of global health},
  year={2015},
  volume={81 5},
  pages={
          669-74
        }
}
BACKGROUND Leukocyte migration (LM) and intracellular killing aspects of the innate immune response play important roles in protection against and containment and cure of Mycobacterium tuberculosis infection, and thus may be exploited as immunotherapeutic targets to improve the management and treatment outcomes of patients with tuberculosis (TB). OBJECTIVES The aim of this study was to assess LM and mediators of intracellular killing in patients with TB at the time of diagnosis and during… CONTINUE READING
BETA